Candriam Equities L Biotech.R CHF Acc H/ LU1269736754 /
| NAV9/21/2023 | Chg.-1.8700 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 181.0200CHF | -1.02% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | - | - | - | - | - | - | - | - | 3.81 | -8.64 | -3.97 | -2.99 | - |
| 2017 | 5.37 | 6.71 | -0.01 | 0.96 | -3.17 | 9.25 | 2.21 | 6.79 | 0.75 | -6.79 | -0.06 | 1.28 | +24.55% |
| 2018 | 6.46 | -4.80 | -2.39 | -3.41 | 4.34 | 0.58 | 4.21 | 3.87 | -2.28 | -14.26 | 3.88 | -8.61 | -13.65% |
| 2019 | 12.82 | 3.37 | -0.81 | -5.23 | -4.67 | 9.15 | -2.44 | -2.53 | -4.73 | 10.96 | 11.86 | 2.51 | +31.48% |
| 2020 | -5.43 | -1.60 | -5.43 | 12.23 | 9.44 | 1.20 | -3.00 | 0.78 | 0.58 | -2.71 | 9.32 | 2.87 | +17.67% |
| 2021 | 1.79 | -2.63 | -4.46 | 2.68 | -2.30 | 6.28 | -1.49 | 3.84 | -4.29 | 0.13 | -4.43 | 2.29 | -3.23% |
| 2022 | -10.64 | -1.64 | 5.83 | -7.32 | -4.11 | 3.15 | 4.61 | 1.26 | -2.38 | 6.20 | 5.78 | -3.39 | -4.31% |
| 2023 | 2.65 | -5.92 | -0.03 | 1.99 | -1.27 | 1.11 | -0.85 | -0.55 | -3.58 | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 14.40% | 13.21% | 17.55% | 20.95% | 23.52% |
| Sharpe ratio | -0.90 | -0.44 | -0.14 | -0.25 | -0.08 |
| Best month | +2.65% | +1.99% | +6.20% | +9.32% | +12.82% |
| Worst month | -5.92% | -3.58% | -5.92% | -10.64% | -14.26% |
| Maximum loss | -10.53% | -8.70% | -12.61% | -31.53% | -31.53% |
| Outperformance | -5.08% | - | -3.25% | - | - |
All quotes in CHF
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.V US... | reinvestment | 1,802.2700 | +6.55% | +3.49% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 196.4300 | -2.35% | - | |
| Candriam Equities L Biotech.I EU... | reinvestment | 1,830.4399 | +3.17% | -3.47% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 1,973.0100 | -1.35% | +13.63% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,079.5701 | -1.86% | +6.29% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 322.4400 | -1.94% | +9.07% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 288.0200 | -1.47% | +15.37% | |
| Candriam Equities L Biotech.R CH... | reinvestment | 181.0200 | +1.47% | -3.93% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,607.4301 | +6.59% | +5.52% | |
| Candriam Equities L Biotech.I US... | reinvestment | 4,983.7998 | +4.99% | +4.19% | |
| Candriam Equities L Biotech.V US... | reinvestment | 527.8700 | +5.02% | +0.90% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 175.6800 | +2.96% | -4.17% | |
| Candriam Equities L Biotech.R US... | reinvestment | 235.7200 | +4.98% | +5.78% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 182.1800 | +3.28% | -1.85% | |
| Candriam Equities L Biotech.C US... | reinvestment | 739.1700 | +5.42% | +2.25% | |
| Candriam Equities L Biotech.C US... | paying dividend | 679.1400 | +5.39% | +2.15% |
Performance
| YTD | -6.54% | ||
|---|---|---|---|
| 6 Months | -0.94% | ||
| 1 Year | +1.47% | ||
| 3 Years | -3.93% | ||
| 5 Years | +10.34% | ||
| 10 Years | - | ||
| Since start | +20.68% | ||
| Year | |||
| 2022 | -4.31% | ||
| 2021 | -3.23% | ||
| 2020 | +17.67% | ||
| 2019 | +31.48% | ||
| 2018 | -13.65% | ||
| 2017 | +24.55% | ||